Pyoderma faciale in a patient with Crohn's disease

Area of Science:

• Dermatology
• Gastroenterology
• Internal Medicine

Background:

• Pyoderma faciale is a rare, severe facial dermatitis.
• Crohn's disease is a chronic inflammatory bowel disease.
• The co-occurrence of these conditions presents unique clinical challenges.

Observation:

• A patient with established Crohn's disease developed pyoderma faciale.
• Two distinct instances of pyoderma faciale relapse were observed.
• These relapses temporally correlated with the initiation of non-steroidal anti-inflammatory drug (NSAID) therapy.

Findings:

• NSAIDs may exacerbate or trigger pyoderma faciale in susceptible individuals, particularly those with inflammatory bowel disease.
• Isotretinoin treatment demonstrated efficacy in resolving the patient's pyoderma faciale.
• The therapeutic course with isotretinoin was well-tolerated by the patient.

Implications:

• This case highlights a potential adverse drug reaction between NSAIDs and pyoderma faciale in Crohn's disease patients.
• It suggests careful consideration of NSAID use in patients with co-existing pyoderma faciale and Crohn's disease.
• Isotretinoin represents a viable therapeutic option for managing pyoderma faciale in this complex patient population.